The PRISMA-P reporting guideline for writing a protocol for a systematic review
How to use this reporting guideline
You can use reporting guidelines throughout your research process.
- When writing: Consider using a writing guide to draft your manuscript or protocol.
- After writing: Complete a checklist and include it with your journal submission.
- To learn: Consult the guidance whenever you need it.
However you use PRISMA-P, please cite it.
Applicability criteria
Summary of guidance
Although you should describe all items below, you can decide how to order and prioritize items most relevant to your study, findings, context, and readership whilst keeping your writing concise. You can read how PRISMA-P was developed in the FAQs.
Title | |
1a. Identification | Identify the report as a protocol of a systematic review. |
1b. Update | If the protocol is for an update of a previous systematic review, identify as such. |
Registration | |
2. Registration | If registered, provide the name of the registry (such as PROSPERO) and registration number. |
Authors | |
3a. Contact | Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of corresponding author. |
3b. Contribution | Describe contributions of protocol authors and identify the guarantor of the review. |
Amendments | |
4. Amendments | If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, state plan for documenting important protocol amendments. |
Support | |
5a. Sources | Indicate sources of financial or other support for the review. |
5b. Sponsor | Provide name for the review funder and / or sponsor. |
5c. Role of sponsor or funder | Describe roles of funder(s), sponsor(s), and / or institution(s), if any, in developing the protocol. |
Introduction | |
6. Rationale | Describe the rationale for the review in the context of what is already known. |
7. Objectives | Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO). |
Methods | |
8. Eligibility criteria | Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review. |
9. Information sources | Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other grey literature sources) with planned dates of coverage. |
10. Search strategy | Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated. |
11a. Study records - data management | Describe the mechanism(s) that will be used to manage records and data throughout the review. |
11b. Study records - selection process | State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis). |
11c. Study records - data collection process | Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators. |
12. Data items | List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications. |
13. Outcomes and prioritization | List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale. |
14. Risk of bias in individual studies | Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis. |
15a. Data synthesis | Describe criteria under which study data will be quantitatively synthesised. |
15b. Data synthesis | If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ). |
15c. Data synthesis | Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression). |
15d. Data synthesis | If quantitative synthesis is not appropriate, describe the type of summary planned. |
16. Meta-bias(es) | Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies). |
17. Confidence in cumulative evidence | Describe how the strength of the body of evidence will be assessed (such as GRADE). |
We like publishing transparent research because we think it’s more likely to be used and cited. That’s why we ask authors to use reporting guidelines.
Robin Lavery
Editor, International Journal of World Medicine
Ready to get started?
Protocol
A protocol is the plan or set of steps to be followed in a study. A protocol for a systematic review should describe the rationale for the review; the objectives; and the methods that will be used to locate, select and critically appraise studies, and to collect and analyse data from the included studies. Protocols can, and probably should, be amended. A plan may change because the nature of a review changes. The key thing is that the amendments to the protocol need to be noted, together with the reasons. Protocols are good things because they make you think about what you are going to do, and why.
Source